Xeltis Investors

21 investors on Angel Roster list Xeltis in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in France, Spain and Switzerland.

Investors are matched on the company name in their portfolio, so companies that share the name Xeltis can appear together.

Investors listed
21
With verified email
24%
Most common stage
Seed
Top location
France

Updated October 13, 2026 · How we compile this data

Top 21 Xeltis investors

The most complete profiles first. Showing 21 of 21.

  • Cristina GarmendiaVerified

    Venture Capital · Spain

    SeedPre-SeedHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: TiGenix, AM Pharma, Ona Therapeutics, STAT-Dx and 27 more

    Verified email available

  • Philippe PeltierVerified

    Venture Capital, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: Implanet, AM Pharma, FeetMe, Advanced Perfusion Diagnostics and 36 more

    Verified email available

  • Thierry LaugelVerified

    Venture Capital, Private Equity Firm, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Verified email available

  • Vanessa MalierVerified

    Venture Capital, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Verified email available

  • Alain NicodVerified

    Venture Capital, Private Equity Firm · Switzerland

    Health CareHospitalsCryptocurrencyCRM

    Portfolio: HighLife, Activaero, L.E.S.S., ESBATech and 42 more

    Verified email available

  • Amine MAROUF

    Venture Capital, Private Equity Firm, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Drew Burdon

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Hadrien Bouchez

    Venture Capital, Private Equity Firm, Investor · Netherlands

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Martijn Kleijwegt

    Venture Capital, Private Equity Firm, Investor · Netherlands

    Series BHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Rudy Dekeyser

    Venture Capital, Private Equity Firm, Investor · Belgium

    Series BHealth CareHospitalsLife ScienceMobile

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Sylvain Cascarino

    Venture Capital, Private Equity Firm, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Vincent Brichard

    Private Equity Firm, Investor · Netherlands

    SeedHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Arnd Kaltofen

    Venture Capital, Private Equity Firm · Switzerland

    Health CareHospitalsCryptocurrencyCRM

    Portfolio: HighLife, Activaero, L.E.S.S., ESBATech and 42 more

    Contact details available

  • Benedikt Luhmann

    Venture Capital · Switzerland

    Health CareHospitalsCryptocurrencyCRM

    Portfolio: HighLife, Activaero, L.E.S.S., ESBATech and 42 more

    Contact details available

  • Diego Braguglia

    Venture Capital, Private Equity Firm · Switzerland

    Health CareHospitalsCryptocurrencyCRM

    Portfolio: HighLife, Activaero, L.E.S.S., ESBATech and 42 more

    Contact details available

  • Guillem Laporta, CFA

    Venture Capital, Private Equity Firm · Spain

    Health CareWomen FoundedLife ScienceManufacturing

    Portfolio: TiGenix, AM Pharma, Ona Therapeutics, STAT-Dx and 27 more

    Contact details available

  • Iñigo López

    Venture Capital, Private Equity Firm · Spain

    Health CareWomen FoundedLife ScienceManufacturing

    Portfolio: TiGenix, AM Pharma, Ona Therapeutics, STAT-Dx and 27 more

    Contact details available

  • Jessica Vitos

    Venture Capital · Spain

    Health CareWomen FoundedLife ScienceManufacturing

    Portfolio: TiGenix, AM Pharma, Ona Therapeutics, STAT-Dx and 27 more

    Contact details available

  • Jordi Xiol

    Venture Capital, Private Equity Firm · Spain

    Health CareWomen FoundedLife ScienceManufacturing

    Portfolio: TiGenix, AM Pharma, Ona Therapeutics, STAT-Dx and 27 more

    Contact details available

  • Merijn Klaassen

    Private Equity Firm · Netherlands

    Health CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Peter Neubeck

    Venture Capital, Private Equity Firm · Germany

    Health CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

Frequently asked questions

How many Xeltis investors are on Angel Roster?

Angel Roster lists 21 Xeltis investors. 5 of them (24%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (19) and Private Equity Firms (16). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Xeltis investors invest in?

Among those that list a stage, the most common are Seed (8), Series B (3) and Pre-Seed (1).

Where are Xeltis investors based?

Most are based in France (5), Spain (5) and Switzerland (4).

Which companies have Xeltis investors backed?

The most-backed portfolio companies among them are OxThera (17), AM Pharma (17), Medlumics (16), Orphazyme (12) and STAT-Dx (12).

How do I contact Xeltis investors?

Create a free Angel Roster account to search and filter all 21, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.